AstraZeneca Pharma gains 3% on plan to launch cancer drug in India News News / News 6 years ago 465 Views comments Osimertinib is an oral anti-cancer drug for management of lung cancer. Read more
News Will review decisions taken by Cong govt; law and order among top priorities: Jai Ram Thakur News / News - 6 years ago
News Bet on actively managed duration funds to earn high teen returns post RBI policy News / News - 6 years ago
News Building blocks for re-optimisation are in place: TechM CEO CP Gurnani News / News - 6 years ago
Comments